Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparations used in clinical organ transplantation

James M. Mathew*, Manuel Carreno, Laphalle Fuller, George W. Burke, Gaetano Ciancio, Camillo Ricordi, Andreas G. Tzakis, Violet Esquenazi, Joshua Miller

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Background. Cadaver donor bone marrow cells (DBMC) are capable of a low-grade response to allogeneic stimulation in vitro, indicating their potential ability to cause graft versus host disease (GvHD). However, at this center, we have observed a lack of GvHD in kidney transplant recipients who received DBMC perioperatively. Therefore, we questioned whether an intrinsic immunoregulatory function of (subpopulations of) DBMC might play a role in this observation. Methods. In in vitro assays, DBMC was added to autologous splenic responder cells taking part in allogeneic mixed lymphocyte reaction (MLR) and cell-mediated lympholysis (CML) reactions. Results. When compared with autologous donor irradiated spleen cells as control modulators, DBMC significantly inhibited the CML, but to a much lesser extent than MLR, of autologous responding cells stimulated with allogeneic irradiated cells in a dose dependent manner. The down-regulation of CML responses was observed even in the presence of pharmacological concentrations FK506, mycophenolic acid, or cyclosporine-A. The inhibition could not be overcome by the addition of exogenous helper factors. Moreover, in contrast with findings previously reported from this laboratory of the in vitro inhibitory effect of DBMC on allogeneic responding cells in MLR and CML reactions to stimulating cells of the DBMC donor (allogeneic host versus graft inhibition), the following unique observations were made using DBMC inhibiting autologous reactions (GvH): (1) optimal restimulation of autologous responder cells in secondary cultures could not abrogate this inhibition; even activated responder cells could be inhibited by autologous DBMC, and (2) soluble factors were at least partially operative in this autologous (GvH) inhibition as indicated by experiments in transwells and by the CML inhibition caused by 50% supernatants from DBMC cultures. Conclusion. These in vitro results indicate that DBMC treatment brings about a marked down-regulation of autologous immunocompetent cells in cytotoxicity reactions, partially at least through secreted soluble factor(s), (and in presence of immunosuppressive drugs in vivo) thereby preventing overt clinical GvHD.

Original languageEnglish (US)
Pages (from-to)846-855
Number of pages10
Issue number6
StatePublished - Sep 27 2002

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparations used in clinical organ transplantation'. Together they form a unique fingerprint.

Cite this